These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12907596)

  • 1. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
    Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
    Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
    Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
    Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
    Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
    Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
    Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
    Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
    Shima Y; Honma Y; Kitabayashi I
    Cancer Res; 2013 Jul; 73(14):4278-88. PubMed ID: 23722549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression.
    Möller A; Sirma H; Hofmann TG; Staege H; Gresko E; Lüdi KS; Klimczak E; Dröge W; Will H; Schmitz ML
    Oncogene; 2003 Nov; 22(54):8731-7. PubMed ID: 14647468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.
    Tomasini R; Samir AA; Carrier A; Isnardon D; Cecchinelli B; Soddu S; Malissen B; Dagorn JC; Iovanna JL; Dusetti NJ
    J Biol Chem; 2003 Sep; 278(39):37722-9. PubMed ID: 12851404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
    Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
    Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tyrosine Kinase c-Abl Promotes Homeodomain-interacting Protein Kinase 2 (HIPK2) Accumulation and Activation in Response to DNA Damage.
    Reuven N; Adler J; Porat Z; Polonio-Vallon T; Hofmann TG; Shaul Y
    J Biol Chem; 2015 Jul; 290(27):16478-88. PubMed ID: 25944899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
    Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
    Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulatory control of the p53 response by Siah-1L-mediated HIPK2 degradation.
    Calzado MA; de la Vega L; Muñoz E; Schmitz ML
    Biol Chem; 2009 Oct; 390(10):1079-83. PubMed ID: 19642869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tyrosine autophosphorylation on catalytic activity and subcellular localisation of homeodomain-interacting protein kinases (HIPK).
    van der Laden J; Soppa U; Becker W
    Cell Commun Signal; 2015 Jan; 13():3. PubMed ID: 25630557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N; Asakawa M; Umezawa K; Segawa K
    Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.